Bioptron HPL BROCHURE PMB-325-18-EN 17 09 2019-NEW
Bioptron HPL BROCHURE PMB-325-18-EN 17 09 2019-NEW
Bioptron HPL BROCHURE PMB-325-18-EN 17 09 2019-NEW
® ®
(hyperpolarized light)
1
All these painful and life-threatening conditions have to be medically treated. Every year, worldwide 600 billion US dollars are spent on
pharmaceuticals (chemical drugs). Despite the efficacy, the risk of serious side effects and the costs involved treatment with medicaments
is both dangerous and expensive. It makes no sense.
2
BIOPTRON® Quantum Hyperlight has been accepted as a unique
form of treatment, DISEASE PREVENTION, THERAPY and RECOVERY
for various medical indications and health issues:
– Wound healing
– Pain relief
– Skin diseases - dermatological disorders
– Mental disorders, depression and seasonal affective disorders (SAD)
– Pediatrics
– Dentistry
– Anti-ageing
– Veterinary care
3
Connective tissue
Secretion of EPIDERMIS
collagen matrix
DERMIS
Migration to wound
Fibroplast
All over the world, in reputable hospitals and institutions, wellness and sports centers, health professionals are using BIOPTRON® Quantum
Hyperlight and are reporting the following significant improvements while treating patients who suffer from various medical conditions:
4
By way of introduction, BIOPTRON AG was founded in 1988 in Switzerland. In 1996, the company became a part of the Zepter Group.
BIOPTRON® has since become a brand that stands for innovative medical healthcare products, unrivalled in both prevention and recovery
for a number of medical conditions.
BIOPTRON® QUANTUM HYPERLIGHT already helped millions of people to improve their body’s ability to repair itself and maintain
optimal health. It speeds up the healing process, restores impaired body functions and one’s metabolic balance, increases resistance to
external stressors and increases immunity by accelerating the body’s natural healing processes for both acute and chronic conditions.
Certificates:
BIOPTRON® is in full compliance with high quality
standards and medical device requirements in
accordance with the EU Medical Devices Directive,
93/42/EEC. It is also approved by the FDA (510
(k) clearance for pain, No.: K032216) for the US
market and is registered as a medical device in
Australia (TGA certificate) and Canada (Health
Canada certificate).
5
INTERNATIONAL AWARDS AND GOLD MEDALS FOR THE INVENTION OF BIOPTRON®
QUANTUM HYPERLIGHT (HYPERPOLARIZED LIGHT) AND TESLA HYPERLIGHT EYEWEAR
Gold Medal, Gold Medal, Gold Medal, Gold Plaque and WIPO Medal
China Association Invent Arena, International Federation Gold Medal, for Inventors,
of Inventions, Trinec, 2018 of Inventors’ Association, Inventions Belgrade, 2018
Foshan, 2018 Geneva, 2018 Belgrade, 2018
Prof. in Nanotechnology
Dr. Djuro Koruga
6
BIOPTRON® QUANTUM HYPERLIGHT FOR A QUANTUM BODY
BIOPTRON AG works at the highest scientific level, taking
reference and developments from physics, chemistry, quantum
mechanics and medical science. The company develops and
produces clinically tested and certified high-tech medical devices
that generate Hyperpolarized Light and/or Quantum Hyperlight
that acts at the quantum level, restoring the whole body system.
The word quantum is derived from the Latin word quanta, which
denotes the smallest amount of energy information influencing
body molecules and atoms responsible for healthy elementary
processes.
7
STRUCTURED HYPERLIGHT RESTORES SELF-SIMILAR STRUCTURED BODY-MATTER
Due to a number of diseases or even the body’s natural ageing
process, the natural healthy state in biological structures becomes
unordered, causing continued illnesses and accelerated ageing.
8
COMMUNICATION
85% of the human body has the
same ideal type of symmetry as HLPL:
biomolecules, water-chains, clusters,
clathrin, microtubules, collagen, centrioles,
targets, flagella and processes based on
Gibbs free energy/negative ions, water
65%, proteins 15% and lipids 5%.
HPL TESLA TOROID = CLATHRIN
A microscopic view of a clathrin
Due to its Tesla Quantum toroidal properties, based on Fibonacci Sequence, this light emission penetrates deep through the tissue,
reaching the very important protein – clathrin, and harmonizing it. Clathrin recognizes a self-similar Quantum Hyperlight symmetry pattern
and through the energy resonance principles conveys the proper necessary energy information, at the quantum level, into the cell. The
endocytic pathways are thereby ideally energized directly with Quantum Hyperlight as the source of proper energy (even without “classic”
food as the main energy-mediator)!
9
“If all the information required to control the body’s biochemical
processes is in the light that the body emits, and if disturbances
in that light disrupt biochemical processes and cause disease,
then it must be possible to “examine” the light and remove the
disease.“ - Dr Fritz Albert Popp.
The thought processes of the human brain are also fed from light as
the main energy source. An improper "light diet” (not enough light)
causes malillumination, which implies serious illnesses: light is the
basic nutrient of all life.
10
Biolight is made up of biophotons (from the Greek word “βιος” meaning “life” and “φϖς” meaning “light”). Biophotons must be
distinguished from the more commonly discussed physical photons. Biophotons are defined as the electromagnetic radiation of
biomolecules. Dr. Popp, F.A. demonstrated that cells emit either a structured healthy light responsible for good health, or a chaotic light
which indicates disease. The explanation here is simple: if biophotons manage the body’s biochemical processes in a chaotic manner,
the symmetry will be disrupted.
The healthy human body possesses the highest level of harmony. Sick individuals with weak immune systems have a poor and chaotic
level of harmony, disturbed coherence and disturbed biophoton cellular communication.
Once the cellular metabolism is compromised, the cell becomes isolated from the regulated process of natural growth control. BIOPTRON®
Quantum Hyperlight - as structured light could establish the natural healthy state in the biophoton cellular communication. (Influence of
light on biophotons, Dr. Johan Boswinkel, Institute for Applied Biophoton Science IABS).
11
BIOPTRON® TECHNOLOGY INSPIRED BY THE NOBEL PRIZE WINNING DISCOVERY OF C60
Niels Ryberg
Finsen
12
– The Nobel Prize in physiology or medicine in 1903 was awarded to Dr. Niels Ryberg Finsen. He demonstrated the efficacy of ordered light
for medical treatment of various diseases, such as Lupus Vulgaris, also known as tuberculosis of the skin (cutaneous tuberculosis). He is
therefore considered the founder of modern light therapy.
– The Nobel Prize in chemistry was awarded in 1996 to Sir Harold W. Kroto, Robert F. Curl and Richard E. Smalley for discovering C60 as
a Fibonacci structure – icosahedral entity. These three researchers together with a British-American team from the Rice University in the U.S.
managed to obtain the nano-molecule fullerene C60 during experiments with graphite. Based on the discovery of C60, BIOPTRON® scientists
invented the C60 Tesla Hyperlight Optics® which acts as a nanophotonic generator of Quantum Hyperlight. The influence of
BIOPTRON® Quantum Hyperlight on matter (biostructures) is at its most efficient. This is the quantum phenomenon whereby the information
is able to modify the matter, bringing the whole body into homeostasis.
– The Nobel Prize in chemistry in 2011 was awarded to Dan Shechtman for
discovering a periodic icosahedral phase transition process and structures
(quasicrystals) by Fibonacci’s Law (quasicrystals are also known as
Fibonacci crystals, since they naturally arrange according to the Golden
Ratio, the same spatial arrangement present in photons of Hyperpolarized Light).
13
MOLECULE C60 - Bucky ball
C60 belongs to the fullerene family (C60, C70, C76, C82 and C84
molecules).
It is one of the eight allotropic forms of carbon in nature (the well-
known forms are graphite and diamond).
In a natural state it is so rare that C60 is a molecule composed of 60 carbon atoms arranged in
it may be found in the most hidden a geometric shape called a truncated icosahedron with the
places and only in trace amounts. It Fibonacci structure. It is the only molecule of a single element
was found in a meteorite in Canada to form a spherical cage: C60 has 12 regular pentagonal and
and it has been established that it 20 regular hexagonal faces. No two pentagons share an edge,
was older than the solar system. which could destabilize the structure.
It is believed that it came from cos- The C60 colour is originally black in nature. The patented
mic realms from red giant stars, technology process of fullerene application changes it into the
where it was synthesized and unique BIOPTRON® Quantum Hyperlight colour.
ejected into space.
14
C60 and its healing properties date back to the 18th century.
In the early 1700's, Tzar Peter the Great had a palace in Karelia,
near a magic spa center named “Martial Waters”. The water at the
Martial spa went through the thick layers of shungite (C60) in order
to cure weak stomach, vomiting, diarrhea, hypochondria, kidney
problems, different skin conditions and many other ailments.
15
Emoto’s Quantum Hyperlight Experiment
1. 2.
1. Tap-water crystal (molecule) is irregular, incoherent – unstructured, 2. Emoto’s experiment reveals that when tap-water is exposed to
representing ‘molecular incoherence’, meaning that it is not BIOPTRON® Quantum Hyperlight, it affects the water structure,
symmetric to the body's water. modifying it into a hexagonal water shape crystal that represents
the ultimate state of ‘molecular coherence’.
An Observation Report
Method:10 minutes of HLPL exposure at a distance of 8 cm
The number of observed ice drops: 50
Observation apparatus: Olympus optical microscope (magnification: x 200)
Photographing conditions: freezing temperature: - 25 degrees, freezing time: 4 hours, observation temperature: - 3 degrees
Place & date: Emoto Institute, Japan, March 2018
16
Graphic represents the healthy body's water as structured. Dr. Brill
G.E., Saratov – State Medical University, Russia.
A photograph of fullerene C60, taken by Professor Dr. Djuro Koruga and his team of researchers with a scanning tunneling microscope
(STM) at the Nano Laboratory of the University of Belgrade (1992). This photograph confirms quantum mechanical equations governing
the hexagonal “openings” of the C60 molecule.
17
BIOPTRON® QUANTUM HYPERLIGHT EXPOSURE: LIVE BLOOD CELL ANALYSIS
Live blood cell analysis (dark-field microscopy) after 10 minutes of BIOPTRON® Quantum Hyperlight exposure
Comparison and evaluation
(Picture 1) Red blood cells are clotted, unordered and inactive (clustered structures), which could reveal or lead to cardiovascular diseases,
inflammations and oxygen deficiency at the tissue level (hypoxia).
(Picture 2) After only 10 minutes of LPL exposure, the previous blood formation (clotted, unordered and inactive blood cells), converts (from
clustered structures) into separated groups or isolated red-blood cells with significantly improved blood cell condition: better blood flow
and increased oxygenation - better regeneration.
(Picture 3) After 10 minutes of Quantum Hyperlight (Hyperpolarized Light) exposure, previous clustered structures change into entirely
separated blood cells which embody the entire blood revitalization: from the unhealthy state, microtubules are modified into a torus shape,
obtaining the same energy structure as Quantum Hyperlight, the initial natural healthy state, according to the Golden Ratio (see page No.
24). Empowered with such inconceivable light energy (energy, information and frequency), cells move faster (remarkable anti-coagulating
effect). The red cells revive from inactivity into healthy live active cells, proving that HPL has quantum properties – it heals at the quantum
level. The energized blood flows unrestrictedly through the veins, effortlessly conveying oxygen into the vital organs, improving the
processes of nutrient transport into the cells, facilitating removal of debris and possibly preventing hypertension, thrombosis (hazardous
blood coagulation), stroke, heart attack, inflammation, etc.
BIOPTRON® Quantum Hyperlight can rejuvenate unhealthy cells and recreate vigorous, healthy blood cells (an ideal healthy cell condition
and cell formation), all of which are critical to maintain a healthy body.
1. 2. 3.
18
GENERAL BIOPTRON® HYPERLIGHT FEATURES
1. Brewster's optical unit
2. BIOPTRON® Filters/Optics
3. Low energy light
4. Incoherent light
5. Vertically Linearly Polarized Light
6. Hyperpolarized light
The high-quality Brewster’s optical unit is positioned at a specific angle in the BIOPTRON® device. When the diffuse unordered light from
the light source collides-interacts with the Brewster’s optical unit, it reflects with minimal intensity loss and becomes a perfectly Vertically
Linearly Polarized Light (VLPL).
2.1. Tesla Hyperlight Optics® (Nanophotonic Fullerene Filter) - Energy (eV) 0.02
19
2.2. BIOPTRON® Classical Medical Filter (480 nm to 3400 nm, that is 1.15 - 2.90 eV with a pronounced peak at 720 nm, 1.70 eV).
The VLPL penetrates deep into the tissue, activating various cellular and biological processes that accelerate regenerative and reparative
healing processes, maintaining and restoring cells, tissues and organs to their healthy state (30 years of excellent medical results).
2.3. BIOPTRON® Medical White Filter (400 - 700 nm) Vertically Linearly Polarized WHITE Light acts efficiently as a nerve tonic that
positively influences the pineal gland/ hypothalamus, and promotes inner balance and a peaceful mind. In use as psychotherapeutic and
psycho-stimulating white light.
2.4. BIOPTRON® Medical Blue Filter (450 - 480 nm) Vertically Linearly Polarized BLUE Light is used in dentistry (to fight against bacteria/
periodontitis) and in cosmetic branches of aesthetic medicine (to treat acne vulgaris or rosacea).
2.5. BIOPTRON® Medical Red Filter (570 - 660 nm) Vertically Linearly Polarized RED Light penetrates deep into the body, greatly
reducing pain. Exposure to such light activates the analgesic systems of the brain. Sensitivity to pain and painful edema decrease, while
microcirculation improves. It treats muscle pain and rheumatoid arthritis and it is effective for use in physiotherapy.
Tesla Hyperlight Optics® BIOPTRON® Classical BIOPTRON® Medical BIOPTRON® Medical BIOPTRON® Medical
(Nanophotonic Fullerene Filter) Medical Filter White Filter Blue Filter Red Filter
(VLPL 400 - 13300 nm) (VLPL 480 - 3400 nm) (VLPL 400 - 700 nm) (VLPL 450 - 480 nm) (VLPL 570 - 660 nm)
In addition to medical filters, BIOPTRON® can be equipped with orange, yellow, indigo and violet filters
20
3. Low Energy Light
BIOPTRON® delivers a consistent stream of light with a steady intensity (also known as power density) of abt. 40 mW/cm2 at a distance of
10 cm from the treated area. The dosage of BIOPTRON® Quantum Hyperlight can be precisely determined. It has two components, power
and time: Energy (J) = Power (W) × Time (s) (the Bunsen-Roscoe rule of reciprocity in photobiology). This light emission delivers a dose of
light equivalent to an average energy density of 2.4 J/cm2 per minute. This represents a low and safe dosage of light energy with a great
response in the living matter that stimulates natural healing with no side effects.
Quantum Hyperlight lux with an optimal specific power density of 40 mW/cm2 and an energy density of 2.4 J/cm2, predominantly covers
the electronic energy states of biomolecules from 1.4 to 3.4 eV.
4. Incoherent Light
Quantum Hyperlight is an Incoherent Light (out-of-phase or unsynchronized light), characterized by light waves that are not temporally or
spatially synchronized. Frequent and random changes of phases between light photons of different wave frequencies and wavelengths
make this a low-intensity light. BIOPTRON® incoherent light promotes safe, non-invasive and effective healing processes without the risk
of developing resistance to the therapy. In contrast to this, most laser lights have a high intensity, coherent light which has a high potential
for tissue damage.
6. Hyperpolarized light
21
BIOPTRON® Quantum Hyperlight
Φ2 (1.61803 ) + φ2 (0.61803) = 3
Light source
22
Generating Quantum Hyperlight with Quantum Nano Properties
1. When diffuse light (emitted by a halogen bulb), collides/ interacts with the Brewster's optical unit, it reflects and becomes a Vertically
Linearly Polarized Light (VLPL).
2. When such VLPL passes through the Tesla Hyperlight Optics®, it becomes unprecedented, perfectly-ordered Hyperpolarized Light, called
Quantum Hyperlight.
VLPL interacts with C60 (integrated in the optics), which twists at a near-inconceivable 18 billion times per second. C60 reflects from each
other without friction (paramagnetic and diamagnetic properties). As a result of VLPL interactions with twisting C60, VLPL photons change
their orientation:
a. the 20 hexagons in C60 obtain the Faraday’s effect (the plane of photon polarization rotate in hexagons), and
b. the 12 pentagons in C60 obtain the Fibonacci-sequential effect (the plane of photon polarization rotates and twists in all directions in
pentagons).
23
FIBONACCI SEQUENCE
In mathematics, the Fibonacci numbers are an integer
sequence, called the Fibonacci Sequence, and
characterized by the fact that every number, after the
first two, is the sum of the two preceding ones: 0, 1, 1,
2, 3, 5, 8, 13, 21, 34, 55, 89, 144… Around 1200
AD, the mathematician Leonardo Fibonacci discovered
the unique properties of the Fibonacci sequence. This
sequence directly relates to the Golden Ratio. It can be
applied to the proportions of a rectangle, called the
Golden Rectangle. This is known as one of the most
visually satisfying of all geometric forms: hence the
appearance of the Golden Ratio in art (e.g., the Mona
Lisa and the Last Supper).
75% of the
biomolecules
are arranged
in accordance
with Fibonacci
sequence,
which
resembles
the look of
Fibonacci’s
spiral – the
Golden Ratio.
24
DISTINCTION IN LIGHT PENETRATION AND THE HEALING EFFECTS OF DIFFERENT KINDS OF LIGHT
EPIDERMIS
DERMIS
SUBCUTANEOUS
TISSUE
In general, the penetration of light depends upon both tissue type and the kind of light.
Diffuse light is chaotic, with the disordered electromagnetic fields of photons. This “chaos” acts disorderly on body water molecules with its dipole
moments and on biomolecules with its positive and negative charges (their reunion again creates dipole moments). Diffuse light penetration is
limited with no efficient healing effects. The benefit of diffuse light to repair imbalances exists, but is of minor importance for healing.
25
VLPL Penetration and Its Health Efficiency
a)
Diffuse light is reflected at many angles. It penetrates the
VLPL, with its linearly arranged photons, body only up to 2 - 3 mm depth with no significant healing
assists in the regulation of processes effects and does not influence biological structures, cells
that are linearly determined and has and organs. This light does not possess an ordered photon
the ability to arrange body's water and structure.
Quantum Hyperlight as a unique quantum light with its perfectly ordered photons, according to the Fibonacci Law, penetrates deep into
the body. According to the Fibonacci Law Φ2 (1.61803) + φ2 (0.61803) = 3, dipole moments and biomolecules and electromagnetism in
tissue have the same arrangement as Quantum Hyperlight photons, making it fully compatible with biological structures.
Quantum Hyperlight communicates with the molecules, cells and tissues, conveying the ideal C60 harmony and its energetic state, inducing
harmonization and equilibrium in energetically disturbed biological structures, accelerating natural healing processes. At the same time,
because of the perfect Quantum Hyperlight symmetry, biomolecules directly absorb the energy necessary for life that results from the
electrical and magnetic characteristics of Quantum Hyperlight. In effect, under its influence, the cell is stimulated to heal itself, regaining
its natural equilibrium and energetic properties.
26
BIOPTRON® QUANTUM HYPERLIGHT IS RECOGNIZED AS A UNIQUE
METHOD OF TREATMENT FOR DIFFERENT MEDICAL INDICATIONS
We recommend con-
sulting a physician be-
Blood and the cyrculation system Nervous system fore using BIOPTRON®
Hyperlight therapy in
order to receive profes-
sional advice.
27
According to BIOPTRON® scientific research:
1. Quantum Hyperlight maintains cells, delaying the apoptosis process (natural cell death). It has been shown that Quantum Hyperlight
stimulates cell plasma membranes to promote an optimal healthy state of the cell.
2. Quantum Hyperlight maintains cell functions, reducing the number of necrotic cells, thus reducing the necrosis processes (premature cell
death) [Ref. 12.6].
When Quantum Hyperlight is applied, it penetrates the plasma membranes of dysfunctional cells and creates a spatial rearrangement of
their structural components; it maintains and restores cells in the whole body into their natural, healthy state.
Clathrin
Mitochondrion
28
THE MAIN THERAPEUTIC EFFECTS OF BIOPTRON® QUANTUM HYPERLIGHT:
1. Quantum Hyperlight stimulates tissue self-repair processes and prevents tissue degradation (even for deeper systems, such as nerves, tendons,
cartilage, bones, and internal organs).
– Eradicates pathogenic microorganisms (acne vulgaris, herpes simplex and zoster viruses)
– Activates natural killer cells
– Reduces swelling and hematomas as well as the resolution of inflammation caused by injuries and autoimmune diseases
– Improves deep microcirculation
– Reduces muscle spasms
– Decreases pain transmission by direct action on peripheral nerves
4. Quantum Hyperlight thermo-sensory and opto-sensory stimulation has sensory and neural effects that can reduce the symptoms of SAD
and non-seasonal depression. It can be sensed by the skin (thermo-sensory stimulation) as well as by photoreceptors in the eye (opto-sensory
stimulation).
29
Quantum Hyperlight accelerates the healing
processes - it promotes deep microcirculation
and cell biostimulation at the quantum level,
and in this way improves the body’s defence
system.
The results:
30
BIOPTRON® QUANTUM HYPERLIGHT FOR WOUND HEALING
BIOPTRON® Quantum Hyperlight significantly reduces the time required Conservative approach to deep dermal burn wounds with BIOPTRON®
for complete epithelialization (dermal regeneration) of damaged skin Light Therapy
and reduces scar formation. It helps to accelerate the healing time and
reduces the length of hospital stays while improving life quality.
Start therapy After 15 days After 19 days After 29 days After 9 months
Monstrey et al (2002b)
31
Hypertrophic scarring and superficial second-degree burns can be treated with conventional local medical treatments in combination with
Quantum Hyperlight treatment. Several studies have shown that the routine use of Quantum Hyperlight for the treatment of these burns can
significantly reduce the time necessary for complete epithelialization (regeneration of the skin) of the damaged skin (complete healing),
reducing the risk of scar formation that is functionally and aesthetically unacceptable. Further, Quantum Hyperlight can reduce the need for
surgery in the treatment of deep dermal burns, particularly those located in the areas where the likelihood of scar formation after surgery is
extremely high.
Quantum Hyperlight is a highly valuable choice of treatment in avoiding surgery in patients with deep dermal burns:
– No operation risks
– Less pain
– No skin grafts needed
These wounds often require the surgical removal of dead tissue and transplantation of the skin (skin grafting).
SKIN TUMOR: Treatment with BIOPTRON® Quantum Hyperlight (Courtesy of Dr. Surböck, Mariazell)
32
BIOPTRON® QUANTUM HYPERLIGHT FOR
PAIN RELIEF
Quantum Hyperlight significantly reduces one’s pain sensation [Ref
7.1 - 7.22], swelling and hematomas, and reduces inflammation
caused by injuries, degenerative diseases or autoimmune diseases.
One can experience improved microcirculation, reduced muscle
spasms and the activation of natural pain-killing processes.
33
BIOPTRON® QUANTUM HYPERLIGHT IN DERMATOLOGY/SKIN DISEASES
BIOPTRON® QUANTUM HYPERLIGHT can significantly help to heal skin diseases [Ref 4.1 - 4.5].
These include: atopic dermatitis, herpes simplex, herpes zoster, psoriasis, eczema, rosacea, mucosal injuries, acne and surface bacterial infections.
HLPL stimulates tissue self-repair processes and prevents tissue degradation (even of deeper structures, such as nerves, tendons, cartilage,
bones and internal organs).
In the field of wound healing, it could also help as a complementary therapy for the following conditions: post-surgical wounds, burns,
transplants, healing after trauma, venous ulcers (stasis ulcers), pressure ulcers, skin grafts, venous leg ulcers (stasis ulcers), decubitus
(pressure) sores, diabetic foot ulcers.
The main mechanism of Quantum Hyperlight and its influence on healing wounds without scarring is related to the orthogonal arrangement
of collagen type I and III with collagen type VII in the basal membrane. At the quantum level, it stimulates the basal membrane very rapidly,
which reduces, prevents and averts the formation of scars.
Epidermis
Dermis
34
BIOPTRON® QUANTUM HYPERLIGHT
FOR DERMATOLOGICAL SCALP AND
HAIR DISORDERS
Quantum Hyperlight stimulates the immune system
and stabilizes the production of keratinocytes, whilst
minimizing the occurrence of scaly, flaky scalp patches
and eliminating dryness of the scalp. Quantum
Hyperlight brings back hair shine and strengthens
hair follicles. Early clinical testing has demonstrated a
60% reduction in hair loss during only one month of
treatment [Ref. 14.1 - 14.3].
35
The BIOPTRON® Quantum Hyperlight spectrum promotes
a series of soothing processes in the skin:
36
BIOPTRON® BLUE VERTICALLY LINEARLY POLARIZED LIGHT (VLPL) IN DENTISTRY -
ADJUVANT ORAL TREATMENT
The BIOPTRON® Vertically Linearly Polarized Light efficiently fights
oral infections and/or inflammation, stimulating elastin and
collagen production for faster oral healing [Ref. 8.1].
Clinical Research Box [Ref. 8.2]: Clinical studies have shown that
BIOPTRON® Blue VLPL applied into the oral cavity for ten minutes
during five consecutive days significantly reduces plaque formation
in adult dental patients. Besides, phototherapeutic treatment of dental
diseases of various etiopathogenesis with BIOPTRON® blue spectrum
showed positive influences on immune cells (T-lymphocytes for cell
immunity), increased the local concentration of immunoglobulins (B
lymphocytes for humoral immunity) and stimulates the proliferation of
fibroblasts for the formation of collagen and stimulated angiogenesis
(the formation of new blood vessels).
More importantly, BIOPTRON® Blue VLPL reduced drug load and local
anesthesia and induced local regenerative and immunostimulating
actions. Taken together, these observations contribute to the
improvement of the treatment quality and shorten a disease duration.
BIOPTRON® Blue VLPL has the following properties: antibacterial and
antiviral action, it accelerates healing processes after oral surgery,
supports the periodontal regeneration process after clinical therapy
(periodontal disease and dental plaque), reduces swelling, increases
tissue regeneration and assists in orthodontal pain reduction.
37
BIOPTRON® QUANTUM HYPERLIGHT FOR SEASONAL AFFECTIVE DISORDER (SAD)
BIOPTRON® Quantum Hyperlight is medically approved and ideal for the treatment of seasonal
depression. This system can be used as a monotherapy or in combination with other medical treatments.
Light deprivation and consequently the disruption of the circadian rhythm is associated with the
increased risk of serious psychological disorders, including depression.
Quantum Hyperlight has sensory
and neural effects that can re-
duce the symptoms of seasonal
affective disorder (SAD) and non-
HPL Light
seasonal depression: it has an in-
tensity of more than 10,000 Lux.
Conventional light therapy de-
vices provide a light intensity of
10,000 light units (called Lux). A
daily treatment of about 30 min-
utes is considered effective.
CH
ANT
ARR
IBOD
UTERUS
BONE M
IES
ENDOCRINE IMMUNE
SYSTEM SYSTEM
the luminance of standard room
light is approximately 500
US
OVARY
THYM
IC
THYM
PHAT
Lux; a cloudy day equals up to
LYM
US
TIC
REA
C
TES
LE PAN WH Y
ITE TAR
PARA
THYROID THYROID
BLOO
D CELLS COMPLE
MEN sunlight reaches at least 50,000
Lux [Ref. 9.1-9.6].
38
Clinical Research Box:
Exposure:
20 - 40 min. = 20 cm distance,
40 - 60 min. = 30 cm distance or
60 - 120 min. = 40 cm distance.
The BIOPTRON® pilot study on the neuroendocrine effects of HLPL in the domain of visible and infrared light has shown positive effects.
Researchers have investigated the effects of Quantum Hyperlight through the neuroendocrine-immune system on general blood parameters
(red and white blood cells, hemoglobin, potassium, sodium, etc.) as well as insomnia, depression, heart rhythm, blood pressure, other
parameters and the psychological parameters of personality.
Participants in the study were exposed to BIOPTRON® Quantum Hyperlight in ten minute sessions (3 x per week on the face, with open
eyes, at a 40 cm distance). The results indicated a significant decline in anxiety, even for the subjects within the normal range of values.
There was considerable improvement regarding the somatization of anxiety disorder, i.e. a reduction of cardiovascular, respiratory and
digestive symptomatology, as well as significant improvements in the quality of sleep (evident by improvements in a person’s melatonin
levels).
Results showed increases in serotonin and dopamine levels and decreases in stress hormone. At the same time, the exposure to such light is
beneficial for sleep because of the effects on melatonin, as shown by clinical parameters. As a result, the general recommendation for sleeping
problems with the Quantum Hyperlight is five minutes per day at a distance of 40-60 cm.
39
BIOPTRON® QUANTUM HYPERLIGHT FOR CHILDREN
Quantum Hyperlight can be used for children as a complementary
therapy to reduce pain and promote healing in various types of
conditions, such as: pediatric dermal affections, endogenous eczema,
upper respiratory tract infections, allergic respiratory diseases,
pediatric musculoskeletal disorders and neurological disorders and
deficits. [Ref. 10.1 - 10.4]
40
BIOPTRON® QUANTUM HYPERLIGHT IN VETERINARY MEDICINE
Similar to the medical effects on humans, BIOPTRON® Quantum
Hyperlight is also a recommended and successfully used therapy in
veterinary medicine, in the professional and home care of animals.
41
TECHNICAL INFORMATION - ADVANCED SWISS TECHNOLOGY AND DESIGN -
3 BIOPTRON® DEVICES
The essence of the BIOPTRON® light therapy system consists of five crucial elements:
1. Light source emits (conveys to Brewster’s optical unit) non-polarized, polychromatic and incoherent light,
2. Brewster’s optical unit (a patented five-layered optical system) provides vertical linear polarization of up to 95%,
3. Safety glass,
4. Patented BIOPTRON® Filters/Optics that generate unique BIOPTRON Hyperlights (see page 19),
5. Special certificates for medical devices.
There are three models of the BIOPTRON® device: BIOPTRON® 2, BIOPTRON® Pro1 and BIOPTRON® MedAll.
All BIOPTRON® devices include the same physical characteristics of light and therefore the same beneficial medical effects on the human body.
Devices only differ in design and individual treatment area and size.
The control panel allows the operator to easily program treatment sessions
lasting up to 95 minutes, divisible into one-minute increments. The filter diameter
(approx. 15 cm) permits the treatment of larger areas and hence offers time
effective therapy. The BIOPTRON® 2 guarantees the highest degree of comfort for
all applications and, like other Bioptron Light Therapy devices, is very easy to use.
42
The BIOPTRON® Pro 1 therapy device is designed for use at home, in hospitals,
in treatment centers and other beauty or health care facilities. The device is
available either with a functional floor stand or an ergonomic table stand for more
user-friendly handling. With an easily adjustable height and head inclination, as
well as the ability to rotate the device head up to 360°, this device allows for
convenience and comfort.
Treatment times can be easily set using the control panel down to 30 second
intervals. The filter diameter of the BIOPTRON® Pro 1 (approx. 11 cm) allows for
treatments of various medium-sized areas. An optional wheel set is also available
for easier mobility.
The BIOPTRON® MedAll is a small yet powerful device, easy to use and having
a state-of-the-art technology. It is intended as a personal polarized light therapy
medical device for use in all circumstances and locations. Ergonomic and portable,
it can be carried anywhere; on business or leisure trips, fitting easily into your
handbag or luggage.
It is available with a floor stand and a sleek case for safe storage and transport.
With the 5 cm filter diameter you can cover small, yet precise, treatment areas
while experiencing its benefits throughout your entire body. The innovative standby
mode saves energy, time and money, as this function uses only 0.5 W of power.
The LED timer display (common to all three models of the BIOPTRON® devices)
ensures better visibility in all light conditions and highly effective resolution for easy
reading. The user-friendly device control interface, consisting of smartly designed
buttons, additionally ensures practical and easy usage. Finally, the ergonomic anti-
slip grip, in combination with its modern design and biocompatible allergy-free
material, guarantees easy handling, safety and comfort while holding the device.
43
REFERENCES
1. BIOPTRON® Effects on Water
1.1. Farashchuk NF, Mikhaylova RI, Telenkova OG. Biological testing of water with different structural states in rats and frogs. Gig Sanit. 2014 Mar-Apr; (2): 84-6. (in Russian).
1.2. Farashchuk NF, Rakhmanin YA, Savostikova ON, Telenkova OG. Crystallographic evaluation of structural changes in water. Gig Sanit. 2014 Jul-Aug; (4): 107-9. (in Russian).
1.3. Zilov VG, Khadartsev AA, Bitsoev VD. Effects of polychromatic visible and infrared light on biological liquid media. Bull Exp Biol Med. 2014 Aug; 157(4): 470-2.
2.1. Albrecht-Buehler G (2013, Sept 4) Cell intelligence. Northwestern University Medical School, Chicago. Accessed 9 November 2017. Retrieved from: http://www.
basic. northwestern.edu/g-buehler/FRAME.HTML.
2.2. Beltrán B, Mathur A, Duchen MA, Erusalimsky JD, Moncada S. The effect of nitric oxide on cell respiration: A key to understanding its role in cell survival or death.
Proc. Natl. Acad. Sci. U.S.A. Dec 2000. 97(26): 14602–14607. 2.3. Greco M, Guida G, Perlino E, Marra E, Quagliariello E. Increase in RNA and protein synthesis
by mitochondria irradiated with helium-neon laser. Biochem. Biophys. Res. Commun. Sep 1989. 163(3): 1428–1434.
2.4. Gulyar SA. Limansky YuP. Static magnetic fields and their application in medicine. Kyiv: BIP NASU. 2006. p. 320 (in Russian).
2.5. Gulyar SA. BIOPTRON light therapy and color therapy bibliography and analysis of publications. In: Anthology of light therapy. Medical BIOPTRON technology.
Kyiv: Bogomoletz Institute of Physiology at the National Academy of Sciences of Ukraine. 2009. p. 917-78 (in Russian).
2.6. Gulyar SA. (Editor-in-Chief) ANTHOLOGY OF LIGHT THERAPY. Medical BIOPTRON technologies (theory, clinical application, prospects). Proceeding. Kyiv: Publ.
BIP NASU. 2009. p. 1024 (in Russian).
2.7. Gulyar SA. Nikula TD. Kirilenko EE. Kirilenko EK. Effects of PILER light on the visceral systems: cardio-renal effects. In: Anthology of light therapy. Medical BIOPTRON
technology. Kyiv: Bogomoletz Institute of Physiology at the National Academy of Sciences of Ukraine. 2009. p. 421-29 (in Russian).
2.8. Gulyar SA. Medolight: basic action of LED technology. 6th Ed., augmented. Kyiv: IMIC. 2016. p. 64 (in Ukranian).
2.9. Karu TI, Pyatibrat L, Kalendo G. Mar 1995. Irradiation with He-Ne laser increases ATP level in cells cultivated in vitro. J. Photochem. Photobiol. Mar 1995. 27(3): 219–223.
2.10. Karu TI. Primary and secondary mechanisms of action of visible to near-IR radiation on cells. J. Photochem. Photobiol. Mar 1999. B, 49(1): 1–17.
2.11. Karu TI, Pyatibrat LV, Kalendo GS. Photobiological modulation of cell attachment via cytochrome c oxidase. Photochem. Photobiol. Sci. Off. J. Eur. Photochem.
Assoc. Eur. Soc. Photobiol. Feb 2004 3(2): 211–216.
44
2.12. Karu TI, Pyatibrat LV, Afanasyeva NI. A novel mitochondrial signaling pathway activated by visible-to-near infrared radiation. Photochem. Photobiol. Oct 2004.
80(2): 366–372.
2.13. Karu TI, Pyatibrat LV, Afanasyeva NI. Cellular effects of low power laser therapy can be mediated by nitric oxide. Lasers Surg. Med. Apr 2005. 36(4): 307–314.
2.14. Karu TI, Kolyakov SF. Exact action spectra for cellular responses relevant to phototherapy. Photomed. Laser Surg. Aug 2005. 23(4): 355-361.
2.15. Kubasova T, Horvath M, Kocsis K, Fenyö M. Effect of visible light on some cellular and immune parameters. Immunology and Cell Biology. 1995. 73: 239-244. 45
2.16. Kubasova T, Fenyö M, Somosy Z, Gazso L, Kertesz I. Investigations on biological effect of polarized light. Photochemistry and Photobiology. 1988. 48: 505-509.
2.17. Lane N. Mitochondrial disease: powerhouse of disease. Nature. Mar 2006. 440(7084): 600–602.
2.18. Lane N. Cell biology: power games. Nature. Oct 2006. 443(7114): 901–903.
2.19. Liu H, Colavitti R, Rovira II, Finkel T. Redox-dependent transcriptional regulation. Circ. Res. Nov 2005. 97(10): 967–974.
2.20. Moore P, Ridgway TD, Higbee RG, Howard EW, Lucroy MD. Effect of wavelength on low-intensity laser irradiation-stimulated cell proliferation in vitro. Lasers Surg.
Med. Jan 2005. 36(1): 8–12.
2.21. Nikula TD. Gulyar SA. Moiseenko VO. Biyakova OV. Correction of vasoregulation and hemodynamic disorders in patients with chronic glomerulonephritis and
concomitant arterial hypertension by PILER Light treatment. In: Anthology of light therapy. Medical BIOPTRON technology. Kyiv: Bogomoletz Institute of Physiology at the
National Academy of Sciences of Ukraine. 2009. p. 597-603 (in Russian).
2.22. Pastore D, Greco M, Petragallo VA, Passarella S. Increase in <--H+/e- ratio of the cytochrome c oxidase reaction in mitochondria irradiated with helium-neon laser.
Biochem. Mol. Biol. Int. Oct 1994. 34(4): 817–826.
2.23. Pinheiro AL, Meireles GC, de Barros Vieira AL, Almeida D, Carvalho CM, dos Santos JN. Phototherapy improves healing of cutaneous wounds in nourished and
undernourished Wistar rats. Braz Dent J. 2004; 15 Spec No: SI21-8.
2.24. Samoilova KA, Bogacheva ON, Obolenskaya KD, Blinova MI, Kalmykova NV, Kuzminikh EV. Enhancement of the blood growth promoting activity after exposure
of volunteers to visible and infrared polarized light. I. Stimulation of human keratinocyte proliferation in vitro. Photochemical and Photobiological Sciences. 2004.
Vol.3(1): 96-101.
2.25. Samoilova KA. Perspectives of using phototherapeutical apparatus BIOPTRON in medicine: an interview with professor K. A. Samoîlova by S. Stevanovich. Klin
Khir. 2005 Jul; 7): 63-4. (in Russian).
2.26. Sutherland JC. Biological effects of polychromatic light. Photochem. Photobiol. Aug 2002. 76(2): 164–170.
2.27. Tuby H, Maltz L, Oron U. Induction of autologous mesenchymal stem cells in the bone marrow by low-level laser therapy has profound beneficial effects on the
infarcted rat heart. Lasers Surg. Med. Jul 2011. 43(5): 401–409.
45
2.28. Wong-Riley MT, Liang HL, Eells JT, Chance B, Henry MM, Buchmann E, Kane M, Whelan HT. Photobiomodulation directly benefits primary neurons functionally
inactivated by toxins: role of cytochrome c oxidase. J. Biol. Chem. Feb 2005. 280(6): 4761–4771.
2.29. Yu W, Naim JO, McGowan M, Ippolito K, Lanzafame RJ. Photomodulation of oxidative metabolism and electron chain enzymes in rat liver mitochondria.
Photochem. Photobiol. Dec 1997. 66(6): 866–871.
2.30. Zhevago NA, Samoilova KA, Glazanova TV, Pavlova IE, Bubnova LN, Rosanova OE, Obolenskaya KD. Exposures of human body surface to polychromatic (visible
+ infrared) polarized light modulate a membrane phenotype of the peripheral blood mononuclear cells. Laser Technology. 2002. Vol. 12 (1): 7-24.
2.31. Quevli N. CELL INTELLIGENCE - the Cause of Growth, Heredity and Instinctive Actions . 1916. Cornwall Press. Minneapolis. Minn, Accessed on: 14.01.2019.
Available from: https://archive.org/details/cellintelligence00queviala/page/n3
2.32. Albrecht-Buehler G, Cell Intelligence, Northwestern University, 2009. Accessed on: 14.01.2019. Available from: http://www.basic.northwestern.edu/g-buehler/cellint0.htm
3.1. Aragona SE, Grassi FR, Nardi G, Lotti J, Mereghetti G, Canavesi E, Equizi E, Puccio AM, Lotti T. Photobiomodulation with polarized light in the treatment of
cutaneous and mucosal ulcerative lesions. J Biol Regul Homeost Agents. Apr-Jun 2017. 31(2 Suppl. 2): 213-218.
3.2. Bogacheva ON, Samoilova KA, Zhevago NA, Obolenskaia KD, Blinova MI, Kalmykova NV, Kuz’minykh EV. Enhancement of fibroblast growth promoting activity
of human blood after its irradiation in vivo (transcutaneously) and in vitro with visible and infrared polarized light. Tsitologiia. 2004. 46(2): 159–171.
3.3. Bolton P. The effect of polarized light on the release of the growth factors from the U-937 macrophage-like cell line. Laser Ther. 1992.7(33).
3.4. Colić MM, Vidojković N, Jovanović M, Lazović G. The use of polarized light in aesthetic surgery. Aesthetic Plast. Surg. Oct 2004. 28(5): 324–327.
3.5. Drozhzhin EV, Sidorkina ON. Ozone therapy and phototherapy with polarized polychromatic light in treatment of patients suffering from lower limb critical
ischaemia. Angiol Sosud Khir. 2012; 18(4): 23-7. (in Russian).
3.6. Durović A, Marić D, Brdareski Z, Jevtić M, Durdević S. The effects of polarized light therapy in pressure ulcer healing. Vojnosanit Pregl. 2008 Dec; 65(12): 906-12.
3.7. Gehrke A. Influencing skin surface temperature using incoherent linear-emitted, polarised light from BIOPTRON compact light therapy device. Data on file. 2013.
3.8. Gulyar SA. BIOPTRON-light therapy and resources of its application in surgery. Photobiology and photomedicine. 2012. 9(1-2): 16-30 (in Russian).
3.9. Gulyar SA. Strelchenko II. Jelskii VN. Physiological mechanisms of polychromatic polarized light influence at skin injuries by high temperature. Medical Informatics
and Engineering. 2016. 1(33): 24-35.
3.10. Man’kovskaya IN. Gulyar SA. Effects of polarized light on the development of the wound related process (experimental and clinical observations). In: Anthology
of light therapy. Medical BIOPTRON technology. Kyiv: Bogomoletz Institute of Physiology at the National Academy of Sciences of Ukraine. 2009. p. 276-82 (in Russian).
Hass HL. Therapeutic potentials of the BIOPTRON light: treatment of disorders in wound healing. Krankenpfl J. 1998 Nov; 36(11): 451-3. (in German).
46
3.11. Hass HL. The therapeutic activity of the BIOPTRON-lamp in the treatment of disorders of wound healing. Diabetic gangrene. Krankenpfl J. 1998 Dec; 36(12):
494- 6. (in German). 3.12. Iordanou P, Baltopoulos G, Giannakopoulou M, Bellou P, Ktenas E. Effect of polarized light in the healing process of pressure ulcers. Int
J Nurs Pract. 2002. Feb; 8(1): 49-55.
3.13. Iordanou P1, Lykoudis EG, Athanasiou A, Koniaris E, Papaevangelou M, Fatsea T, Bellou P. Effect of visible and infrared polarized light on the healing process of
full-thickness skin wounds: an experimental study. Photomed Laser Surg. 2009. Apr; 27(2): 261-7.
3.14. Medenica L & Lens M, The use of polarised polychromatic non-coherent light alone as a therapy for venous leg ulceration. Journal of Wound Care. 2003. 12(1): 37- 40.
3.15. Monstrey S, Hoeksema H, Saelens H, Depuydt K, Hamdi M, Van Landuyt K, Blondeel P. A conservative approach for deep dermal burn wounds using polarised-
light therapy. British Journal of Plastic Surgery. 2002. 55: 420-426.
3.16. Monstrey S, Hoeksema H, Depuydt K, Van Maele G, Van Landuyt K, Blondeel P. The effect of polarized light on wound healing. European Journal of Plastic Surgery.
2002. 24(8): 377-382.
3.17. Sharipova MM, Voronova SN, Rukin EM, Vasilenko AM. The comparative assessment of the wound-healing effects of the treatment with the use of BIOPTRON,
Minitag, Orion + apparatuses and hollow cathode lamps (experimental study). Vopr Kurortol Fizioter Lech Fiz Kult. 2011 Jul-Aug;(4): 42-5. (in Russian).
3.18. Tomashuk IP, Tomashuk II. Clinical efficacy of alprostan in combination with “BIOPTRON-II” rays and iruxol-miramistin in the treatment of the diabetic foot
complicated by atherosclerosis. Klin Khir. 2001 Aug; (8): 49-51. (in Russian).
4. BIOPTRON® in Dermatology
4.1. Charakida A, Seaton ED, Charakida M, Mouser P, Avgerinos A, Chu AC. Phototherapy in the treatment of acne vulgaris: what is its role? Am. J. Clin. Dermatol.
2004. 5(4): 211–216.
4.2. Dediulescu L. The BIOPTRON light therapy. Oftalmologia. 2004; 48(4): 70-6. Review. (in Romanian).
4.3. Hass HL. Therapeutic effects of the BIOPTRON light in cosmetic medicine. Acne vulgaris. Krankenpfl J. 1998 Oct; 36(10): 394-5. (in German).
4.4. Monakhov SA, Perminova MA, Shabliî RA, Korchazhkina NB, olisova OIu. The methods of phototherapy for the treatment and prevention of chronic dermatoses.
Vopr Kurortol Fizioter Lech Fiz Kult. 2012 Jul-Aug; (4): 33-6. (in Russian).
4.5. Ulamec M, Soldo-Belić A, Vucić M, Buljan M, Kruslin B, Tomas D. Melanoma with second myxoid stromal changes after personally applied prolonged phototherapy.
Am J Dermatopathol. 2008 Apr; 30(2): 185-7.
5.1. Raeissadat SA, Rayegani SM, Rezaei S, Sedighipour L, Bahrami MH, Eliaspour D, Karimzadeh A. The effect of polarized polychromatic noncoherent light
(BIOPTRON) therapy on patients with carpal tunnel syndrome. J Lasers Med Sci. 2014 Winter; 5(1): 39-46.
47
5.2. Stasinopoulos D, Stasinopoulos I, Johnson MI. Treatment of carpal tunnel syndrome with polarized polycromatic noncoherent light (BIOPTRON light): a preliminary,
prospective, open clinical trial. Photomed Laser Surg. 2005 Apr; 23(2): 225-8.
5.3. Stasinopoulos D. The use of polarized polychromatic noncoherent light as therapy for acute tennis elbow/lateral epicondylalgia: a pilot study. Photomed Laser Surg.
2005 Feb; 23(1):66-9.
5.4. Stasinopoulos D, Stasinopoulos I. Comparison of effects of Cyriax physiotherapy, a supervised exercise programme and polarized polychromatic noncoherent light
(BIOPTRON light) for the treatment of lateral epicondylitis. Clin Rehabil. 2006 Jan; 20(1): 12-23.
5.5. Stasinopoulos D, Stasinopoulos I, Pantelis M, Stasinopoulou K. Comparing the effects of exercise program and low-level laser therapy with exercise program and
polarized polychromatic noncoherent light (BIOPTRON light) on the treatment of lateral elbow tendinopathy. Photomed Laser Surg. 2009 Jun; 27(3): 513-20.
5.6. Stasinopoulos D, Papadopoulos C, Lamnisos D, Stasinopoulos I. The use of BIOPTRON light (polarized, polychromatic, non-coherent) therapy for the treatment of
acute ankle sprains. Disabil Rehabil. 2017 Mar; 39(5):450-457.
5.7. Tondiy OL. Ladnaya ID. Tarasova OI. Use of PILER Light in complex treatment of post neuropathic mimic muscles contractures. In: Anthology of light therapy. Medical
BIOPTRON technology. Kyiv: Bogomoletz Institute of Physiology at the National Academy of Sciences of Ukraine. 2009. p. 645-48 (in Russian).
5.8. Wells J, Konrad P, Kao C, Jansen ED, Mahadevan-Jansen A. Pulsed laser versus electrical energy for peripheral nerve stimulation. J. Neurosci. Methods. Jul 2007.
163(2): 326–337.
6.1. Anashkin KN. Gulyar SA. Opsha IL. Experience of BIOPTRON application in divers. In: Anthology of light therapy. Medical BIOPTRON technology. Kyiv:
Bogomoletz Institute of Physiology at the National Academy of Sciences of Ukraine. 2009. p. 344-47 (in Russian).
6.2. Fenyo M, Mandl J, Falus A. Opposite effect of linearly polarized light on biosynthesis of interleukin-6 in a human B lymphoid cell line and peripheral human
monocytes. Cell Biol Int. 2002; 26(3): 265-269.
6.3. Filatova NA, Knyazev NA, Kosheverova VV, Shatrova AN, Samoilova KA. The effect of radiation with polychromatic visible and infrared light on the tumorigenicity
of murine hepatoma 22A cells and their sensitivity to lysis by natural killers. Cell and Tissue Biology. 2013. Vol.7(6): 573-577. 48
6.4. Gulyar SA. Correction of hyperbaric respiratory syndrome in divers with the help of BIOPTRON polarized light. Clin. and Experim. Pathol. 2004. 4(2). Part 1:101-
103 (in Russian).
6.5. Gulyar SA. Stepanova EI. Kolpakov IE. Vdovenko VYu. Kondrashova VG. Visceral and hemic effects of PILER light in children with acute and chronic radiational
impairment in the zone of Chernobyl’ catastrophe. In: Anthology of light therapy. Medical BIOPTRON technology. Kyiv: Bogomoletz Institute of Physiology at the National
Academy of Sciences of Ukraine. 2009. p. 430-42 (in Russian).
6.6. Gulyar SA. Strelchenko II. Jelskii VN. Influence of polychromatic polarized light combined with near-infrared radiation on neurohumoral, immune and tissue changes
at burn injury. Medical Informatics and Engineering. 2016. 2(34): 15-20.
48
6.7. Hass HL. The effect of BIOPTRON-light in rheumatology. Krankenpfl J. 2000 Dec; 38(11-12): 396-7. (in German).
6.8. Knyazev NA., Samoilova KA, Filatova NA, Galaktionova AA. Effect of polychromatic light on proliferation of tumor cells under condition in vitro and in vivo – after
implantation to experimental animals. Proc SPIE. 2009. Vol.1142: 79-86
6.9. Knyazev NA, Samoilova KA, Abrahamse H, Filatova NA. Downregulation of tumorigenicity and changes in the actin cytoskeleton of murine hepatoma after
irradiation with polychromatic visible and IR light. Photomedicine and Laser Surgery. 2015. Vol. 33(4). P.185-192.
6.10. Knyazev NA, Filatova NA, Samoilova KA. Proliferation and tumorigenicity of murine hepatoma cells irradiated with polychromatic visible and infrared light. Cell
and Tissue Biology. 2013. Vol.7(1): 79-85.
6.11. Knyazev NA, Samoilova KA, Abrahamse H, Filatova NA. Polychromatic Light (480-3400 nm) Upregulates Sensitivity of Tumor Cells to Lysis by Natural Killers.
Photomed Laser Surg. 2016. Sep; 34(9): 373-8.
6.12. Kuznetsova LV. Babadjan VD. Frolov BM. Gulyar SA. et al. The clinical and laboratory immunology. National Textbook. Kyiv: Polygraf Plus. 2012. p.922 (in
Ukrainian).
6.13. Nikolaeva OD. Savitskaya AV. Influence of polarized light on systemic immunity parameters in patients with pulmonary tuberculosis. In: Anthology of light therapy.
Medical BIOPTRON technology. Kyiv: Bogomoletz Institute of Physiology at the National Academy of Sciences of Ukraine. 2009. p. 593-96 (in Russian).®
6.14. Obolenskaya K.D., Samoilova K.A. Comparative study of effects of polarized and nonpolarized light on human blood in vivo and in vitro. I. Phagocytosis of
monocytes and granulocytes. Laser Technology. 2002. Vol. 12(2-3). P.7-13.
6.15. Roberts JE. Visible light induced changes in the immune response through an eye-brain mechanism (photo neuroimmunology). J. Photochem. Photobiol. B, Jul 1995.
29(1): 3–15.
6.16. Samoilova KA, Zubanova OI, Snopov SA, Mukhuradze NA, Mikhelson VM. Single skin exposure to visible polarized light induces rapid modification of entire
circulating blood.
6.17. Samoilova KA, Obolenskaya KD, Vologdina AV, Snopov SA, Shevchenko EV. Single skin exposure to visible polarized light induces rapid modification of entire
circulating blood.
6.18. Samoilova KA, Zimin AA, Buinyakova AI, Makela AM, Zhevago NA. Regulatory systemic effect of postsurgical polychromatic light (480-3400 nm) irradiation of
breast cancer patients on the proliferation of tumor and normal cells in vitro. Photomedicine and Laser Surgery. 2015. Vol. 33(11): 555-563.
6.19. Voronenko YuV. Kuznetsova LV. Gulyar SA. et al. Allergology (Manual). Kyiv. 2009. p. 366 (in Ukrainian).
6.20. Young S, Bolton P, Dyson M, Harvey W, Diamantopoulos C. 1989. Macrophage responsiveness to light therapy. Lasers Surg. Med. 9(5): 497–505. 49
6.21. Zhevago NA, Samoilova KA, Obolenskaya KD. The regulatory effect of polychromatic (visible and infrared) light on human humoral immunity. Photochemical and
Photobiological Sciences. 2004. Vol.3(1): 102-108.
49
6.22. Zhevago N, Samoilova KA. Modulation of proliferation of peripheral blood lymphocytes after irradiation of volunteers with polychromatic visible and infrared
light. Cytology. 2004. 46(6): 567-577.
6.23. Zhevago NA, Samoilova KA. Pro- and anti-inflammatory cytokine content in the human peripheral blood after its transcutaneous and direct (in vitro) irradiation
with polychromatic visible and infrared light. Photomedicine and Laser Surgery. 2006. Vol. 24(2): 129-139.
6.24. Zhevago NA, Samoilova KA, Calderhead RG. Polychromatic light similar to the terrestrial solar spectrum without its UV component stimulates DNA synthesis in
human peripheral blood lymphocytes in vivo and in vitro. Photochemistry Photobiology. 2006. Vol. 82(5): 1301-1308.
6.25. Zhevago NA, Samoilova KA, Davydova NI, Bychkova NV, Glazanova TV, Chubukina ZhV, Buîniakova AI, Zimin AA. The efficacy of polychromatic visible and
infrared radiation used for the postoperative immunological rehabilitation of patients with breast cancer. Vopr Kurortol Fizioter Lech Fiz Kult. 2012 Jul-Aug;(4): 23-32.
(in Russian).
6.26. Zhevago NA, Zimin AA, Glazanova TV, Davydova NI, Bychkova NV, Chubukina ZV, Buinyakova AI, Ballyuzek MF, Samoilova KA. Polychromatic light (480-3400
nm) similar to the terrestrial solar spectrum without its UV component in post-surgical immune rehabilitation of breast cancer patients. J Photochem Photobiol B. 2017.
Jan; 166: 44-51.
7.1. Ballyzek MF, Vesović-Potić V, He X, Johnston A. Efficacy of polarized, polychromatic, noncoherent light in the treatment of chronic musculoskeletal neck and shoulder
pain. 2005. Unpublished material, BIOPTRON AG, Wollerau, Switzerland.
7.2. Gulyar SA. Limansky YuP. Tamarova ZA. Bidkov EG. Analgesic effects of BIOPTRON PILER Light. General Practitioner J. 1999. 4:21-23
7.3. Gulyar SA. Limansky YuP. Tamarova ZA. Pain and BIOPTRON: Treatment of pain syndromes by polarized light. Kyiv: Publ. ZEPTER. 2000. p. 80 (in Russian).
7.4. Gulyar SA. Limansky YuP. The mechanisms of primary reception of electromagnetic waves of optical range. Fiziol. J. 2003.49(2): 35-44 (in Russian).
7.5. Gulyar SA. Limansky YuP. Biofizyczne podstawy laseropunktury oraz mechanizmy działania fal elektromagnetycznych spektrum widzialnego. Biophysical basis of
BIOPTRON light puncture and mechanisms of primary reception of electromagnetic waves of optical range. Akupunktura Polska. 2004. 30(1): 1097-1123 (in Polish).
7.6. Gulyar SA. Limansky YuP. Tamarova ZA. Pain and Color: Treatment of pain syndromes by color polarized light. Kyiv: Publ. Biosvet. 2004. p. 120 (in Russian).
7.7. Gulyar SA. Limansky YP. Tamarova ZA. Suppression of pain by influence of BIOPTRON Polarized Light on acupoints. European Journal of Pain. 5th Congress of the
European Federation of IASP Chapters (EFIC). Istanbul. Sept. 13-16. 2006. 10(1): S212.
7.8. Gulyar SA. Kosakovsky AL (Eds) BIOPTRON PILER Light application in medicine (teaching and methodical manual for physicians). Kyiv: publishers of AA.Bogomoletz Institute of
Physiology at National Academy of Sciences of Ukraine and PL. Shupyk Kyiv Medical Academy of Postgraduate Education at Ministry of Health of Ukraine. 2006. 152 p. (in Ukrainian).
7.9. Gulyar SA. Kosakovsky AL (Eds) BIOPTRON PILER Light application in medicine (teaching and methodical manual for physicians). 2nd Ed. Kyiv: publishers of
AA.Bogomoletz Institute of Physiology at National Academy of Sciences of Ukraine and PL. Shupyk National Medical Academy of Postgraduate Education at Ministry
of Health of Ukraine. 2011. p. 256 (in Russian).
50
7.10. Gulyar SA. Tamarova ZA. Physiological mechanisms of polarized light influence on pain. Medical Informatics and Engineering. 2016. 1(33): 41-46. 50
7.11. Gulyar SA. Tamarova ZA. Analgesic Effects of the Polarized Red+Infrared LED Light. Journal of US-China Medical Science. 2017. 14(2) Mar.-Apr. (Serial Number
106): 47-57.
7.12. Gulyar SA. Tamarova ZA. Analgesic and Sedative Effects of Blue LED Light in Combination with Infrared LED Irradiation. Journal of US-China Medical Science.
2017. 14(4). July-Aug. (Serial Number 108): 143-156.
7.13. Gulyar SA. Tamarova ZA. Anti-pain and sedative action of polychromatic polarized light which passed through nano modification by Fullerene or graphene. Proc.
XLVII Internat. Sci-Pract. Conf. Kyiv. October. 12-14. 2017. Kyiv. 2017. p. 95-97.
7.14. Katz EJ. Ilev IK. Krauthamer V. Kim DH. Weinreich D. Excitation of primary afferent neurons by near-infrared light in vitro. Neuroreport. Jun 2010. 21(9): 662– 666.
7.15. Limansky Yu.P. Tamarova ZA. Gulyar SA. Bidkov EG. Examination of polarized light analgesic action on acupuncture points. Fiziol. Zhurnal. 2000. 46(6): 105-111.
7.16. Limansky YP. Tamarova ZA. Gulyar SA. Suppression of visceral pain by action of the low intensity polarized light on antinociceptive points of acupuncture. Fiziol.
Zhurnal J. 2003. 49(5):43-51 (in Russian).
7.17. Limansky YP. Tamarova ZA. Gulyar SA. Parallel testing of analgesia evoked by polarized light and analgetics. Fiziol. Zhurnal. 2005. 51(2): 57-64 (in Russian).
7.18. Limansky YP. Tamarova ZA. Gulyar SA. Suppression of pain by exposure of acupuncture points to polarized light. Pain Res. Manag. 2006. Spring. 11(1):49-57.
7.19. Limansky YP. Gulyar SA. Tamarova ZA. BIOPTRON-Analgesia: 10. The participation of the opioidergic system in the analgesic effect of polarized light on the
analgesic acupuncture point. In: Anthology of light therapy. Medical BIOPTRON technology. Kyiv: Bogomoletz Institute of Physiology at the National Academy of
Sciences of Ukraine. 2009. p. 266-75 (in Russian).
7.20. Ozdemir F. Birtane M. Kokino S. The clinical efficacy of low-power laser therapy on pain and function in cervical osteoarthritis. Clin. Rheumatol. 2001. 20(3):
181– 184.
7.21. Tamarova ZA. Limansky YuP. Gulyar SA. Antinociceptive effects of color polarized light in animal formalin test model. Fiziol. J. 2009. 55(3): 81-93 (in Russian).
7.22. Zamorsky II. Gulyar SA. Changes of prooxidant-antioxidant homeostasis in front brain of rats under the influence of BIOPTRON device polarized light on
acupuncture point. Fiziol. Zhurnal.
8. BIOPTRON® in Dentistry
8.1. Denis TGS, Dai T, Hamblin MR. Killing bacterial spores with blue light: when innate resistance meets the power of light. Photochemistry and Photobiology. 2013. 89(1): 2–4.
8.2. Pärnänen P. Tervahartiala T. Sorsa T. Gieselmann D. McNamara MM. Oral Phototherapy with BIOPTRON MedAll and Periosafe - aMMP-8 test. University of Helsinki
and Helsinki University Hospital. IADR Conference, San Francisco, USA. March 2017. Poster Presentation for Novel Approaches to treat Periodontal Disease.
51
9. BIOPTRON® for SAD
9.1. Avery DH, Kizer D, Bolte MA, Hellekson C. Bright light therapy of subsyndromal seasonal affective disorder in the workplace: morning vs. afternoon exposure. Acta
Psychiatr. Scand. Apr 2001. 103(4): 267–274.
9.2. Eastman CI, Young MA, Fogg LF, Liu L, Meaden PM. Bright light treatment of winter depression: a placebo-controlled trial. Arch. Gen. Psychiatry. Oct 1988. 55(10):
883–889. 51
9.3. Golden RN, Gaynes BN, Ekstrom RD, Hamer RM, Jacobsen FM, Suppes T, Wisner KL, Nemeroff CB. The efficacy of light therapy in the treatment of mood disorders:
a review and meta-analysis of the evidence. Am. J. Psychiatry. Apr 2005. 162(4): 656–662.
9.4. Lam RW, Levitt A. Canadian Consensus Guidelines for the Treatment of SAD, A Summary of the Report of the Canadian Consensus Group on SAD, Can J Diagnosis
1998; Suppl.
9.5. Lee TM, Chan CC. Dose-response relationship of phototherapy for seasonal affective disorder: a meta-analysis. Acta Psychiatr. Scand. 1999. 99(5): 315–323.
9.6. Partonen T, Lönnqvist J. Bright light improves vitality and alleviates distress in healthy people. J. Affect. Disord. Mar 2000. 57(1–3): 55–61.
10.1. Burkin I, Okateyev V. The use of BIOPTRON Light Therapy in the treatment of children with musculoskeletal injuries. Clinical Experience Report. Traumatology
Department. Sperandsky; Municipal Children’s Hospital. Moscow. Russia. 2004.
10.2. Cerná O. The BIOPTRON Light Therapy in the life support and intensive care unit. Congress Proceedings. Prague. Czechoslovakia. 2005.
10.3. Khan MA. Report on use of BIOPTRON polychromatic incoherent polarized light in paediatrics. Russian Scientific Centre of Reconstructive Medicine and
Balneotherapy. Moscow. Russia. 2001.
10.4. Khan MA, Erdes SI. Clinical efficiency of BIOPTRON polychromatic polarized light in the treatment of atopic dermatitis and frequent respiratory diseases in
children. Allergology and Immunology in Paediatrics. 2008. N3 (14).
11.1. Faculty of Veterinary Medicine. University of Belgrade. The Effects of BIOPTRON light therapy on wound healing in Dogs. Internal Report. Belgrade. Serbia.
11.2. Gulyar S. Tamarova Z. Analgesic Effects of the polarized red+infrared LED light. Journal of US-China Medical Sciences. 2017. 14:47-57
11.3. Kehrli, J. Urlich A. 1988. Therapeutic Lamp Emitted Polarized Light (BIOPTRON). Patent (USA) 5. 001. 608. -P8.
11.4. Kehrli J. Ulrich A. 1989. Patent (European) EP 0 311 125 B1. European Patent Office (BIOPTRON). - P9.
52
11.5. Limansky Y. Gulyar S. Tamarova Z. 2009. BIOPTRON-Analgesia: 12. Role of Color in Tonic Pain Suppression. In Anthology of Light Therapy. Medical BIOPTRON
Technologies. Kyiv: Bogomoletz Institute of Physiology at the National Academy of Sciences of Ukraine. 722-31. (in Russian)
11.6. Limansky Y. Gulyar S. Tamarova Z. 2009. BIOPTRON-Analgesia: 2. Comparative Estimation of Antinociceptive Action of Polarized and Non-polarized Light. In
Anthology of Light Therapy. Medical BIOPTRON Technologies. Kyiv: Bogomoletz Institute of Physiology at the National Academy of Sciences of Ukraine, 190-203. (in
Russian)
11.7. Radoji~ić B, Jestrotić D. 2018.The effect of BIOPTRON HLPL in the treatment of high-milk cow mastitis, University of Belgrade, Faculty of Veterinary Medicine,
Veterinary office Vet-Velvet, Acta Veterinaria Brno (In press)
12.1. Filimonova NB. Makarchuk NE. Gulyar SA. Influence of short-term ocular exposition of fullerene light on the activity of default chains of the human brain. Proc.
XLVII Internat. Sci-Pract. Conf, Kyiv. October. 12-14. 2017. Kyiv. 2017. p. 118-120. 52
12.2. Gulyar SA. Tamarova ZA. Modification of Polychromatic Linear Polarized Light by Nanophotonic Fullerene and Graphene Filter Creates a New Therapeutic
Opportunities. Journal of US-China Medical Science. 2017. Koruga, Dj., Hyperpolarized Light: Fundamentals of nano-medical photonics. Submitted for publication,
Zepter Book World 2017.
12.3. Koruga, Dj., Optical filter and method of manufacturing an optical filter, Patent: PCT/EP2016/063174, Applicant Fieldpoint, Cyprus, ZEPTER GROUP, 2016
12.4. Litchinitser MN. Structured Light Meets Structured Matter. Science. Aug 2012: Vol. 337, Issue 6098, pp. 1054-1055
12.5. Piazza L, Lummen TTA, Quiñonez E, Murooka Y, Reed BW, Barwick B, Carbone F. Simultaneous observation of the quantization and the interference pattern of a
plasmonic near- field. Nat. Commun. 2015.6: 6407.
12.6. Ting L, Klein R, Knio O, Vortex Dominated Flows: Analysis and Computation for Multiple Scale Phenomena, Spronger, Berlin, 2007
13.1. Beguin A. One month Treatment with BIOPTRON® 2 Lamp on 10 Subjects. Cosmetic efficacy Results. 2003. Skin Test Institute. Intercosmetica Neuchatel SA.
Neuchatel. Switzerland.
13.2. Beguin A, Vranic S. (1) Evaluation of the enhanced cosmetic efficacy of cosmetic products due to the synergistic activity with BIOPTRON® Pro 1 light therapy
system. (2) Evaluation of the cosmetic efficacy of the BIOPTRON® Pro Light therapy system. One and Two Month test results. 2007. Skin Test Institute. Intercosmetica
Neuchatel SA. Neuchatel. Switzerland.
13.3. Gulyar SA. Antioxidant profile and longevity. Kyiv: Publ. ZEPTER. 1999. p. 48 (in Russian).
13.4. Gulyar SA. (ed.). BIOPTRON-Color Therapy, Handbook. Kyiv: Zepter, 1999. p. 104 (in Russian).
53
13.5. Vranic S. 8-week cosmetic efficacy study of BIOPTRON® Pro 1 device for anticellulite performance on 11 Caucasian female volunteers. Product applications with
the Vita Hand Massager. 2013. Skin Test Institute. Intercosmetica Neuchatel SA. Neuchatel. Switzerland.
13.6. Vranic S. 8-week cosmetic efficacy study of BIOPTRON® Pro 1 device for anticellulite performance on 11 Caucasian female volunteers. Product applications with
bare hands. 2013. Skin Test Institute. Intercosmetica Neuchatel SA. Neuchatel. Switzerland.
13.7. Vranic S. BIOPTRON® and Raman Effect. Activation of skin moisturisation. 2017. Skin Test Institute. Intercosmetica Neuchatel SA. Neuchatel. Switzerland (In progress).
14.1. Vranic S. 8-week. Pilot cosmetic efficacy study of BIOPTRON® Pro 1 device for scalp treatment on 6 Caucasian female volunteers. Assessment on scalp and hair.
2012. Skin Test Institute. Intercosmetica Neuchatel SA. Neuchatel. Switzerland
14.2. Vranic S. 8-week. Pilot cosmetic efficacy study of BIOPTRON® Pro 1 device for hair shedding reduction on 6 Caucasian female volunteers. 2012. Skin Test Institute.
Intercosmetica Neuchatel SA. Neuchatel. Switzerland.
14.3. Vranic S. 8-week. Evaluation of the combined cosmetic efficacy of BIOPTRON® Pro 1 device and a hair treatment (3 products) in reducing hair loss. 8-week
monocentric efficacy study on 10 healthy Caucasian male and female volunteers. 2014. Skin Test Institute. Intercosmetica Neuchatel SA. Neuchatel. Switzerland.
BIOPTRON AG. Research CTE09B/R, unpublished material, 2013. BIOPTRON AG. Research CTE202B/R, unpublished material, 2013. BIOPTRON AG. Research
CTE150B/R, unpublished material, 2013. 53
15.1. Pandi-Perumal SR, BaHammam AS, Brown GM, et al. Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.
Neurotox Res. 2013 Apr; 23(3):267-300.
15.2. Feng Z, Qin C, Chang Y, Zhang JT. Early melatonin supplementation alleviates oxidative stress in a transgenic mouse model of Alzheimer’s disease. Free Radic
Biol Med. 2006 Jan 1;40(1):101-9.
15.3. Borah A, Mohanakumar KP. Melatonin inhibits 6-hydroxydopamine production in the brain to protect against experimental parkinsonism in rodents. J Pineal Res.
2009 Nov; 47(4):293-300.
15.4. Reiter RJ, Sainz RM, Lopez-Burillo S, Mayo JC, Manchester LC, Tan DX. Melatonin ameliorates neurologic damage and neurophysiologic deficits in experimental
models of stroke. Ann N Y Acad Sci. 2003 May; 993:35-47; discussion 48-53.
15.5. Chang HM, Wu UI, Lan CT. Melatonin preserves longevity protein (sirtuin 1) expression in the hippocampus of total sleep-deprived rats. J Pineal Res. 2009 Oct;
47(3):211-20.
15.6. Bubenik GA, Konturek SJ. Melatonin and aging: prospects for human treatment. J Physiol Pharmacol. 2011 Feb; 62(1):13-9.
15.7. Wang JZ, Wang ZF. Role of melatonin in Alzheimer-like neurodegeneration. Acta Pharmacol Sin. 2006 Jan;27(1):41-9.
54
15.8. Wu YH, Swaab DF. The human pineal gland and melatonin in aging and Alzheimer’s disease. J Pineal Res. 2005 Apr; 38(3):145-52.
15.9. Atanassova PA, Terzieva DD, Dimitrov BD. Impaired nocturnal melatonin in acute phase of ischaemic stroke: cross-sectional matched case-control analysis. J
Neuroendocrinol. 2009 Jul; 21(7):657-63.
16. Biophotons
16.1. Rattemeyer M, Popp FA, Nagl W. Evidence of photon emission from DNA in living systems, 1981; 68 (11): 572-573.
16.2. Popp FA, Li K, Gu Q. Recent advances in biophoton research and its application, World scientific, 1992; 1-18.
16.3. Popp FA, Quao G, Ke-Hsuen L. Biophoton emission: experimental background and theoretical approaches, Modern Physics Letters B, 1994; (21-22) 8.
16.4. Popp FA, Chang JJ, Herzog A, Yan Z, Yan Y. Evidence of non-classical (squeezed) light in biological systems. Physics Letters A, 2002; 293 (1-2):98-102.
16.5. Cohen S, Popp FA. Biophoton emission of the human body. Journal of Photochemistry and Photobiology B: Biology, 1997; 40(2): 187-189.
55
56
© Copyright 2017 - Zepter International - Code: PMB-325-18-EN - 2019 09 17
BIOPTRON AG, Sihleggstrasse 23, CH - 8832 Wollerau, Switzerland
Phone: + 41 - 43 - 888 28 00, Fax: + 41 - 43 - 888 28 99
www.bioptron.com, www.zepter.com